Synthroid

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Synthroid

Synthroid is a brand name for the medicine whose active ingredient is Levothyroxine Sodium. It is an essential, prescription-only medication classified as a Thyroid Hormone Replacement agent, intended to compensate for low thyroid hormone production in the body.

Property Description
Active Ingredient Levothyroxine Sodium (L-thyroxine)
Form Oral Tablet (Oral Solid Dosage Form)
Pharmacological Class Thyroid Hormone Replacement / Endocrine Therapeutic Agent
General Purpose Restoring systemic metabolic regulation
Origin Synthetic (Bioidentical)

What Type of Medicine is Synthroid?

Synthroid belongs to the Endocrine Therapeutic Agent class and provides a synthetic version of the naturally occurring primary thyroid hormone, T4 (thyroxine). Levothyroxine Sodium is classified as a core replacement therapy agent. This means the drug serves as a precise substitute for the hormone the thyroid gland fails to produce adequately. Unlike many generic equivalents, the specific brand formulation of Synthroid is clinically recognized for maintaining consistent potency and stability, which is a critical consideration for a medication used over many years.

Composition and Origin: Is Levothyroxine Synthetic?

The active compound, Levothyroxine Sodium, is entirely synthetic, a chemically manufactured compound that is structurally bioidentical to the natural hormone. This distinction ensures a highly consistent and pure active ingredient. Its formulation as an Oral Solid Dosage Form (a tablet) allows for precise, standardized dosing. Levothyroxine is manufactured in various strengths, each typically identified by a distinct tablet color, which is a key differentiating feature designed to help both patients and healthcare providers prevent identification errors. The synthetic origin facilitates the pharmaceutical control necessary for a medicine requiring fine adjustments over a patient’s lifetime.

What is the General Purpose of Levothyroxine?

The fundamental purpose of this medication is to restore metabolic regulation across the body. By supplementing the deficient T4 levels, Levothyroxine ensures that vital processes—including energy utilization, protein synthesis, and temperature control—can function correctly. The action supports the overall hormonal equilibrium essential for the continuous and proper health of nearly all tissues and organ systems. A typical scenario involves the long-term maintenance of the hormone balance necessary for sustained, healthy cardiovascular and cognitive function.

What side effects are possible with Synthroid?

Possible Side Effects and Safety Information

The safety profile of Levothyroxine Sodium is primarily defined by adverse reactions that are signs of hyperthyroidism (overactive thyroid), typically resulting from a dose that constitutes therapeutic overdosage. These effects are listed in regulatory documents and reflect the consequences of excess thyroid hormone in the body.

Documented Adverse Reactions

Adverse effects are categorized by the physiological systems affected, including the Cardiovascular (e.g., palpitations, tachycardia, arrhythmias), Central Nervous System (e.g., nervousness, headache, insomnia, tremors), Musculoskeletal (e.g., muscle weakness), and General/Constitutional (e.g., heat intolerance, excessive sweating, weight loss). Partial hair loss may be observed during the first few months of therapy.

Serious Safety Considerations

The official labeling documents several serious adverse reactions, particularly the risk of Myocardial Infarction, worsening of Congestive Heart Failure, and other serious arrhythmias, especially in elderly patients and those with pre-existing cardiovascular disease. Decreased Bone Mineral Density is also a documented risk associated with long-term therapy at doses higher than the replacement requirement, especially for postmenopausal women.

Regulatory Restrictions

Levothyroxine is contraindicated in conditions such as untreated subclinical or overt thyrotoxicosis and uncorrected adrenal insufficiency. Regulatory warnings also explicitly state that the medication is NOT indicated for the treatment of obesity or weight loss.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents define Levothyroxine Sodium (Synthroid) overdose manifestations as being consistent with signs of hyperthyroidism or thyrotoxicosis. The documented symptoms primarily involve hypermetabolic and neuro-psychiatric effects, including palpitations, tachycardia (rapid heart rate), tremors, excessive sweating, fever, hyperactivity, and nervousness.


Severe Outcomes and Emergency Action

The official prescribing information warns that overdose can lead to serious or even life-threatening manifestations of toxicity. These severe outcomes are explicitly documented to include myocardial ischemia, myocardial infarction (heart attack), the worsening of congestive heart failure, cardiac arrest, and death. This risk is particularly noted for elderly patients and individuals with underlying cardiovascular disease.

Regulatory guidance mandates that medical help be sought immediately if an overdose is suspected or if severe symptoms, such as chest pain or trouble breathing, emerge. The official instruction is to call emergency services right away. Since there is no specific antidote documented, management is officially specified as symptomatic and supportive. This includes administering activated charcoal to reduce absorption and continuous monitoring, including of vital signs and an Electrocardiogram (ECG), due to the critical nature of the documented cardiovascular risks.

Therapeutic Uses of Synthroid

What Synthroid Treats: Main Uses and Benefits

Synthroid (levothyroxine) is a medication used in the management of conditions and distressing symptoms that arise from insufficient natural thyroid hormone. Its use is relevant across domains where additional symptomatic support is needed, with a focus on symptom management and supportive care. Therapeutic applications include treating hypothyroidism and its use is considered relevant in the management of certain types of thyroid cancer.

Symptomatic Relief for Hypothyroidism

Synthroid is commonly used across conditions presenting with systemic imbalance like hypothyroidism, where the body experiences symptoms related to a deficiency of thyroid hormone. It helps address symptom clusters that may become intense or disruptive, such as fatigue, cold intolerance, and sluggishness. The primary therapeutic focus is on providing support that may help ease the overall symptom burden. This approach assists with maintaining functional stability, which may contribute to improved day-to-day comfort during periods when symptoms are more noticeable.

“The aim is to help patients cope more steadily with symptom fluctuations and support general well-being during symptomatic phases.”

Quick Fact: Used for managing symptoms that interfere with daily functioning

Supportive Management in Thyroid Cancer

The medication is considered relevant in conditions involving systemic or localized discomfort, such as certain types of thyroid cancer. It is applied in clinical settings that involve acute or unstable symptom patterns where supportive symptom management is appropriate. This use is relevant when additional symptomatic support is needed and is helpful in situations requiring additional symptomatic assistance.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Synthroid (Levothyroxine Sodium)

The eligibility criteria for Synthroid are determined by official regulatory documents, primarily defining populations who are prohibited from use and those who require conditional, restricted use. The medicine is broadly approved for use in replacement therapy for hypothyroidism across all age groups, including adults and pediatric patients (neonates to adolescents).


Absolute Contraindications

Synthroid must not be used in individuals with:

  • Uncorrected Adrenal Insufficiency: Use may precipitate an acute adrenal crisis.
  • Overt Thyrotoxicosis: Untreated or subclinical hyperthyroidism.
  • Acute Myocardial Infarction (MI) or other acute heart conditions.
  • Known hypersensitivity to the active ingredient or tablet excipients.

Populations Requiring Restricted Use

Use is permitted but requires caution, a lower starting dose, and rigorous monitoring for:

  • Older Adults (ge 65 years) and patients with pre-existing cardiovascular disease.
  • Patients with diabetes mellitus, as the medication may require adjustments to insulin or antidiabetic therapy.

Pregnancy and Lactation Status

Treatment is permitted and should be maintained throughout pregnancy; dosage often increases. Use during lactation is also permitted, as only minimal amounts pass into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Levothyroxine Sodium (Synthroid) based on administration timing, pharmacodynamic outcomes, and metabolic effects.

Administration-Timing Dependent Interactions

Many substances interfere with the medicine's absorption. Antacids containing aluminum, calcium, or magnesium, Sucralfate, Oral Iron and Calcium Salts, and Bile Acid Sequestrants (e.g., Cholestyramine) must be administered at least 4 hours before or after Synthroid to prevent a significant reduction in levothyroxine exposure.

Pharmacodynamic and Metabolic Interactions

Co-administration with Levothyroxine modifies the activity of several drug classes. It potentiates the effect of Oral Anticoagulants (e.g., Warfarin), requiring careful monitoring of clotting parameters. Levothyroxine may also reduce the blood-sugar-lowering effect of anti-diabetic agents, necessitating careful assessment of blood glucose control. Drugs such as Phenytoin and Carbamazepine are documented to enhance the metabolic breakdown of thyroid hormones, potentially requiring a dosage adjustment of levothyroxine. Use with substantial doses of Sympathomimetic Amines used for weight reduction is formally restricted due to the risk of severe toxicity.

Mechanism of Action

Synthroid, which is levothyroxine, is a synthetic form of the naturally occurring thyroid hormone thyroxine (T4). Upon systemic administration and distribution, levothyroxine functions as a prohormone. It is subject to deiodination by deiodinase enzymes, primarily in peripheral tissues such as the liver, kidney, and brain, converting it into the biologically active form, triiodothyronine (T3).

T3 is the principal agonist for the nuclear thyroid hormone receptors (TRs), specifically TRalpha and TRbeta. After T3 diffuses across the cell membrane and enters the nucleus, it binds to the TRs, which are typically heterodimerized with retinoid X receptors ( RXR) and are bound to thyroid hormone response elements ( TREs) in the promoter regions of target genes. This binding event causes a conformational change in the TR/ RXR complex, leading to the dissociation of corepressor proteins and the recruitment of coactivator proteins.

This cascade initiates transcriptional activation or repression of numerous genes involved in essential cellular processes, including metabolism, oxygen consumption, and protein synthesis. The resultant modulation of gene expression dictates system-level physiological consequences by influencing basal metabolic rate, cardiac function (e.g., heart rate and contractility), and overall cellular energy expenditure.

Dosage and Administration Information

How to Use Synthroid: Official Administration Guidelines

Synthroid (Levothyroxine Sodium) tablets are an oral medication used for long-term hormone replacement therapy. Proper use follows established guidelines to ensure consistent absorption and dose accuracy.

Administration Scope

Instruction Domain Official Requirement
Route of Administration Oral (by mouth), as a tablet.
Dosing Frequency Once Daily. Treatment is typically life-long.
Timing Relative to Meals Must be taken on an empty stomach, ideally 30 minutes to 1 hour before breakfast.
Drug Separation Rule Separate administration by at least four hours from products containing iron, calcium, or antacids to prevent impaired absorption.

Official Dosing and Adjustment Rules

Dosage is highly personalized. The full replacement dose for generally healthy adults is approximately 1.6 mcg/kg/day.

  • Dose Titration: Adjustments are typically made in small increments (12.5 mcg to 25 mcg) until the appropriate hormone balance is achieved.
  • Adjustment Interval: Dose changes are monitored every four to six weeks because the full therapeutic effect of a dose change requires this duration to stabilize.
  • Special Populations: Older adults or patients with existing heart conditions begin with a lower initial dose (e.g., 12.5 mcg to 25 mcg) and undergo a slower titration schedule (every six to eight weeks).

Preparation and Handling

For infants and small children unable to swallow tablets, the tablet may be crushed and suspended immediately in a small amount of water (5 to 10 mL) for administration. The prepared suspension must not be stored.

Recent Clinical Evidence

Evidence for Hormone Replacement in Hypothyroidism

Levothyroxine was evaluated in the context of replacement therapy for conditions characterized by hormone deficiency (overt hypothyroidism). The regulatory framework acknowledges the evidence base for this indication, where studies primarily monitor TSH stabilization as a biochemical endpoint. Research on Subclinical Hypothyroidism (SCH) includes Randomized Controlled Trials (RCTs) and meta-analyses. These studies explored outcomes like Quality of Life (QoL), fatigue, and cardiovascular risk markers. While TSH alignment is reported, findings were mixed and heterogeneous across studies when assessing non-biochemical outcomes such as QoL.

Evidence for TSH Suppression and Long-Term Outcomes

Levothyroxine was also evaluated in studies exploring its role in managing certain thyroid cancers by achieving TSH suppression. This evidence is derived mainly from large-scale observational cohort studies and systematic reviews that monitored patients over long periods. Research examined oncologic endpoints such as disease-free survival. Findings indicate patterns where TSH suppression was associated with patterns related to disease-specific survival outcomes. These same observational studies also monitored patterns related to long-term outcomes across the body, including changes in bone mineral density (BMD) and cardiovascular events.

Research in Specific Populations and Uncertainties

Research examined diverse populations. Specific RCTs focused on older adults with SCH, where clinical trial results described no clear pattern regarding the risk of cardiovascular events or mortality compared to placebo during the study period. Studies explored outcomes in pediatric patients (growth and neurological development measures) and pregnant individuals (preterm birth rates). The evidence landscape highlights several areas where certainty remains low. There is limited information from adequately powered RCTs regarding the association between treating SCH and hard clinical endpoints like major heart disease events. Findings were mixed regarding consistent improvement in subjective, patient-reported outcomes like fatigue.

Frequently Asked Questions (FAQ)

Common questions about Synthroid (FAQ)

Q: How quickly does Synthroid start working after I begin taking it?

Official product information describes that the medicine takes time to reach stable levels in the body. While a quick difference in symptoms may not be felt, the full therapeutic effect of a dose change requires a monitoring period of approximately four to six weeks.

Q: How long does it take to feel a noticeable difference from Synthroid?

Studies and official information suggest that it may take several weeks before an improvement in subjective symptoms is reported. This timeline is due to the long period required for the medicine to balance thyroid hormone levels in the bloodstream.

Q: Is Synthroid the same as other thyroid medicines like Levoxyl?

The active ingredient in Synthroid is levothyroxine sodium, which is structurally the same as in other levothyroxine products. However, due to the drug’s narrow therapeutic index, small differences in formulation can be clinically relevant. Official documents describe that thyroid-stimulating hormone (TSH) levels are monitored following any switch in product.

Q: Are there any long-term effects of taking Synthroid?

Official warnings indicate that long-term over-replacement with thyroid hormone may lead to decreased bone mineral density, particularly in postmenopausal women. Regulatory guidance therefore describes the use of the lowest effective dose as a measure to mitigate this potential risk.

Q: Can taking Synthroid affect my weight?

Official regulatory warnings explicitly state that this medication is not indicated for the treatment of obesity or for weight loss. Rapid or excessive weight loss is listed as an adverse reaction that may occur if the prescribed dose is too high, signaling therapeutic overdosage.

Q: Are there any specific vitamins or supplements that interact with Synthroid?

Official documentation confirms that products containing iron salts or calcium salts can interfere with the medicine's absorption. For this reason, regulatory sources describe that these supplements must be administered at least four hours apart from Synthroid.

Q: Can my coffee interfere with how well Synthroid works?

Official product instructions specify taking the medication on an empty stomach because various substances, including beverages like coffee, can interfere with its absorption. Administration instructions detail taking the medicine with water, at least 30 to 60 minutes before breakfast or a caffeine-containing drink.

Q: Does Synthroid affect my mood or energy levels?

Thyroid hormone replacement therapy is associated with the relief of hypothyroidism symptoms like fatigue and low energy. However, adverse reactions linked to excessive dosing, such as nervousness and insomnia, may affect mood and energy levels.

Q: What happens if I stop taking Synthroid suddenly?

Stopping the medication suddenly can have serious health consequences because the body requires a consistent supply of thyroid hormone to support metabolic and organ functions. Untreated hypothyroidism can lead to severe and life-threatening conditions, such as myxedema coma.

Q: How does being over- or under-treated with Synthroid affect the body?

Over-treatment is associated with signs of hyperthyroidism, such as rapid heartbeat (arrhythmias) or weight loss. Conversely, under-treatment can lead to a persistence or worsening of hypothyroidism symptoms, including fatigue, depression, and sensitivity to cold.

Q: Is it possible for a pharmacist to substitute Synthroid with a generic?

A pharmacist's ability to substitute the Synthroid brand with a generic equivalent depends on local regulation and practice. Official guidance acknowledges that due to levothyroxine's narrow therapeutic range, a specific brand may be chosen if a patient's symptoms persist after a change in product.

Q: Why are people often prescribed Synthroid after thyroid removal surgery?

The medicine is indicated for use in managing certain types of thyroid cancer following surgery. In this context, it is used to achieve TSH suppression, which involves lowering the level of thyroid-stimulating hormone (TSH) as an element of disease management.

Q: Why is taking Synthroid consistently so important?

The medicine has a long half-life, meaning it stays in the body for an extended period. Because the body requires a stable, consistent amount of thyroid hormone to regulate metabolism, taking the medication consistently is required to maintain balanced hormone levels and avoid undesirable fluctuations.

Q: Can Synthroid be used to treat thyroid nodules that are not cancerous?

Official clinical guidance describes that the use of levothyroxine to suppress TSH is not routinely recommended for managing benign thyroid nodules in patients who have adequate iodine intake.

Q: Are there any known interactions between Synthroid and birth control pills?

Official drug interaction information notes that products containing estrogens, which includes certain birth control pills, may affect the body’s requirement for thyroid hormone. This effect may be associated with a need for dose adjustment to maintain hormone balance.

Q: What should I do if I accidentally miss a dose of Synthroid?

Patient counseling information describes the general guidance for a missed dose. If a dose is missed, the recommendation is typically to take it as soon as it is remembered that same day. However, if it is almost time for the next scheduled dose, the guidance is to skip the missed dose and resume the usual schedule. Taking two doses simultaneously is not advised.

Q: Can certain common pain relievers interact with Synthroid?

Official drug interaction information notes that certain common pain relievers, such as high-dose salicylates (aspirin) and certain NSAIDs, may interact. These drugs may affect how the body handles the thyroid hormone and are also described as potentially increasing the risk of bleeding in patients taking oral anticoagulants.

Q: Is Synthroid considered a high-risk medication?

The medicine is generally recognized as a Narrow Therapeutic Index (NTI) drug. This classification means that small differences between the effective dose and the potentially harmful dose exist. Because of this, careful monitoring by a healthcare professional is a requirement.

Q: Does Synthroid cause joint pain?

Official sources describe that joint pain (arthralgia) is a reported symptom of untreated or under-treated hypothyroidism. However, it is not consistently listed as a direct side effect of the medicine when taken at the correct replacement dose.

Q: Why do some people take Synthroid in the morning and others at night?

Official product information typically recommends taking the medicine on an empty stomach, 30 to 60 minutes before breakfast. However, some studies have explored taking the dose at bedtime (four hours after the last meal) as an alternative strategy to potentially address issues with drug absorption or patient adherence.

How should Synthroid be stored and disposed of?

How to Store and Dispose of SYNTHROID (Levothyroxine Sodium) Tablets

Synthroid tablets must be stored at a Controlled Room Temperature of 25 C (77 F), with temporary excursions permitted between 15 C and 30 C (59 F and 86 F). The medication requires protection from light and moisture and must be preserved in tight containers.

Handling and Child Safety

The product must be kept out of the sight and reach of children. For stability, if a tablet is crushed and mixed with water, the resulting suspension must be administered immediately and not stored for later use.

Disposal Instructions

Any unused or expired Synthroid must be disposed of in accordance with local regulations. The medicine must not be thrown away with household waste or disposed of via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Synthroid found in:

A-Z Index: